Welcome to LookChem.com Sign In|Join Free
  • or
(±)-methyl 5-amino-4-(2-(benzyloxy)-5-bromo-3,4-dimethoxyphenyl)-6-(6-methoxy-5,8-dioxo-5,8-dihydroquinolin-2-yl)-3-methylpicolinate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

1509897-40-8

Post Buying Request

1509897-40-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1509897-40-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1509897-40-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,0,9,8,9 and 7 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1509897-40:
(9*1)+(8*5)+(7*0)+(6*9)+(5*8)+(4*9)+(3*7)+(2*4)+(1*0)=208
208 % 10 = 8
So 1509897-40-8 is a valid CAS Registry Number.

1509897-40-8Downstream Products

1509897-40-8Relevant academic research and scientific papers

Total synthesis of the antitumor antibiotic (±)-streptonigrin: First- and second-generation routes for de novo pyridine formation using ring-closing metathesis

Donohoe, Timothy J.,Jones, Christopher R.,Kornahrens, Anne F.,Barbosa, Luiz C. A.,Walport, Louise J.,Tatton, Matthew R.,O'Hagan, Michael,Rathi, Akshat H.,Baker, David B.

, p. 12338 - 12350 (2013)

The total synthesis of (±)-streptonigrin, a potent tetracyclic aminoquinoline-5,8-dione antitumor antibiotic that reached phase II clinical trials in the 1970s, is described. Two routes to construct a key pentasubstituted pyridine fragment are depicted, both relying on ring-closing metathesis but differing in the substitution and complexity of the precursor to cyclization. Both routes are short and high yielding, with the second-generation approach ultimately furnishing (±)-streptonigrin in 14 linear steps and 11% overall yield from inexpensive ethyl glyoxalate. This synthesis will allow for the design and creation of druglike late-stage natural product analogues to address pharmacological limitations. Furthermore, assessment of a number of chiral ligands in a challenging asymmetric Suzuki-Miyaura cross-coupling reaction has enabled enantioenriched (up to 42% ee) synthetic streptonigrin intermediates to be prepared for the first time.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 1509897-40-8